Real World Data on Safety and Efficacy of Pegylated Interferon (PEG-IFN) in Patients with Myeloproliferative Neoplasms (MPN)

被引：0
|
作者：
Garg, Mamta [1 ]
Agarwal, Siddharth [2 ]
Asagba, Graham [1 ]
机构：
[1] Univ Hosp Leicester, Leicester, Leics, England
[2] Univ Nottingham, Radiol, Nottigham, England
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190467
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV)
    Younossi, Zobair M.
    Limongi, Dolores
    Stepanova, Maria
    Pierobon, Mariaelena
    Afendy, Arian
    Mehta, Rohini
    Baranova, Ancha
    Liotta, Lance
    Petricoin, Emanuel
    JOURNAL OF PROTEOME RESEARCH, 2011, 10 (02) : 774 - 779
  • [22] Real World Data on Obstetric (OC) and Maternal Complications (MC) Occurring in a Cohort of Patients with Ph Negative Myeloproliferative Neoplasms (MPN): Argentinian Multicentric Study
    Vicente, Angeles
    Heller, Paula G.
    Bendek, Georgina
    Sackmann, Federico
    Ines Varela, Ana
    Castro Rios, Miguel
    Elhelou, Ludmila
    Vallejo, Veronica
    Moiraghi, Beatriz
    Narbaitz, Marina
    Vijnovich Baron, Anahi
    Roveri, Eriberto
    Casali, Claudia
    Ponzinibio, Carlos
    Iastrebner, Marcelo
    Susana Gomez, Maria
    Garcia, Celeste
    Sebastian Peretz, Federico
    Cardenas, Paula
    Enrico, Alicia
    Remaggi, Guillermina
    Boughen, Santiago
    Larripa, Irene
    Carricondo, Emiliano
    Caruso, Vanesa
    Perez, Mariel
    Kornblihtt, Laura
    BLOOD, 2019, 134
  • [23] Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting
    Gill, Harinder
    Leung, Garret M. K.
    Yim, Rita
    Lee, Paul
    Pang, Herbert H.
    Ip, Ho-Wan
    Leung, Rock Y. Y.
    Li, Jun
    Panagiotou, Gianni
    Ma, Edmond S. K.
    Kwong, Yok-Lam
    HEMATOLOGY, 2020, 25 (01) : 247 - 257
  • [24] The efficacy of PEG-IFNα-2a+NUCs therapy in patients with chronic hepatitis B
    Xu, Yan
    Zhang, Yonggui
    Jiao, Jian
    Zhou, Changyu
    Zhao, Ping
    Guo, Honghua
    Li, Yan
    Ji, Shangwei
    Wang, Jiangbin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 638 - 638
  • [25] Efficacy of PEG-interferon α-2B (PEG-IFN) plus ribavirin in responder-relapsers to a previous course of interferon α plus ribavirin
    Basso, M
    Torre, E
    Grasso, A
    Percario, GF
    Azzola, E
    Artioli, S
    Pelli, N
    Picciotto, A
    JOURNAL OF HEPATOLOGY, 2005, 42 : 199 - 199
  • [26] Erythropoictic response to anemia is decreased in patients infected with hepatitis C virus (HCV) receiving combination ribavirin and pegylated interferon (RBV/PEG-IFN) therapy
    Balan, V
    Wu, GY
    Muir, AJ
    Keeffe, EB
    Bowers, PJ
    GASTROENTEROLOGY, 2003, 124 (04) : A751 - A751
  • [27] ANTIGEN PROCESSING AND PROTEASOME DEGRADATION PATHWAYS ARE INVOLVED IN PATIENTS WITH CHRONIC HEPATITIS C WITH NEGATIVE PREDICTORS OF RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN (PEG-IFN/RBV)
    Birerdinc, A.
    Afendy, A.
    Stepanova, M.
    Younossi, I.
    Manyam, G.
    Baranova, A.
    Younossi, Z.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S471 - S471
  • [28] Validation of Central Fatigue (CF) Definition in Patients with Hepatitis C Before, During, and After Treatment with Pegylated Interferon and Ribavirin (PEG-IFN plus RBV)
    Price, Jillian
    Gerber, Lynn
    Nader, Fatema
    Lam, Brian
    Otgonsuren, Munkhzul
    Younossi, Zobair
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S423 - S424
  • [29] Single-dose safety/tolerability and pharamacokinetic/pharmacodynamics (PK/PD) following administration of ascending subcutaneous doses of pegylated-interferon (PEG-IFN) and interferon α-2a (IFN α-2a) to healthy subjects
    Xu, ZX
    Hoffman, J
    Patel, I
    Joubert, P
    HEPATOLOGY, 1998, 28 (04) : 702A - 702A
  • [30] Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients
    Gowin, Krisstina
    Thapaliya, Prakash
    Samuelson, Jan
    Harrison, Claire
    Radia, Deepti
    Andreasson, Bjorn
    Mascarenhas, John
    Rambaldi, Alessandro
    Barbui, Tiziano
    Rea, Catherine J.
    Camoriano, John
    Gentry, Amy
    Kiladjian, Jean-Jacques
    O'Connell, Casey
    Mesa, Ruben
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (10): : 1570 - 1573
12345